• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Function of the hemochromatosis protein HFE: Lessons from animal models.血色素沉着症蛋白HFE的功能:来自动物模型的经验教训。
World J Gastroenterol. 2008 Dec 7;14(45):6893-901. doi: 10.3748/wjg.14.6893.
2
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.转铁蛋白受体调节铁调素表达的Hfe依赖性调控。
Cell Metab. 2008 Mar;7(3):205-14. doi: 10.1016/j.cmet.2007.11.016.
3
Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin.成年Hfe基因缺陷小鼠的铁过载与十二指肠铁转运蛋白DMT1和Ireg1/铁转运蛋白1的稳态表达变化无关。
J Mol Med (Berl). 2004 Jan;82(1):39-48. doi: 10.1007/s00109-003-0508-x. Epub 2003 Nov 15.
4
Regulatory networks for the control of body iron homeostasis and their dysregulation in HFE mediated hemochromatosis.控制机体铁稳态的调节网络及其在HFE介导的血色素沉着症中的失调。
J Cell Physiol. 2005 Aug;204(2):489-99. doi: 10.1002/jcp.20315.
5
Physiologic systemic iron metabolism in mice deficient for duodenal Hfe.十二指肠Hfe基因缺陷小鼠的生理性全身铁代谢
Blood. 2007 May 15;109(10):4511-7. doi: 10.1182/blood-2006-07-036186. Epub 2007 Jan 30.
6
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis.通过对非HFE遗传性血色素沉着症的研究获得对铁稳态的新认识。
Best Pract Res Clin Haematol. 2005 Jun;18(2):235-50. doi: 10.1016/j.beha.2004.09.004.
7
Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.遗传性血色素沉着症蛋白HFE与转铁蛋白受体2的相互作用是转铁蛋白诱导的铁调素表达所必需的。
Cell Metab. 2009 Mar;9(3):217-27. doi: 10.1016/j.cmet.2009.01.010.
8
Non-HFE hemochromatosis.非HFE型血色素沉着症
Semin Liver Dis. 2005 Nov;25(4):450-60. doi: 10.1055/s-2005-923316.
9
Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.铁调素蛋白和转铁蛋白受体 2 的破坏导致小鼠铁诱导的肝损伤。
Hepatology. 2012 Aug;56(2):585-93. doi: 10.1002/hep.25689. Epub 2012 Jun 11.
10
Engineering Peptide Inhibitors of the HFE-Transferrin Receptor 1 Complex.工程化 HFE-转铁蛋白受体 1 复合物的肽抑制剂。
Molecules. 2022 Oct 4;27(19):6581. doi: 10.3390/molecules27196581.

引用本文的文献

1
The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency.天然和合成螯合剂在医学中的重要性和必要性:有效治疗铁过载和缺铁症的前景增加。
Int J Mol Sci. 2024 Apr 25;25(9):4654. doi: 10.3390/ijms25094654.
2
Iron, Copper, and Zinc Homeostasis: Physiology, Physiopathology, and Nanomediated Applications.铁、铜和锌的稳态:生理学、病理生理学及纳米介导的应用
Nanomaterials (Basel). 2021 Nov 4;11(11):2958. doi: 10.3390/nano11112958.
3
Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache.证据表明 HFE H63D 变体是丛集性头痛的潜在疾病修饰因子。
J Mol Neurosci. 2022 Feb;72(2):393-400. doi: 10.1007/s12031-021-01913-8. Epub 2021 Sep 27.
4
New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.使用三价麦芽酚铁和其他亲脂性铁螯合剂复合物治疗缺铁性贫血的新时代:发现的历史视角和未来应用。
Int J Mol Sci. 2021 May 24;22(11):5546. doi: 10.3390/ijms22115546.
5
Higher iron stores and the HFE 187C>G variant delay onset of peripheral neuropathy during combination antiretroviral therapy.铁储存量较高和 HFE 187C>G 变异会延迟联合抗逆转录病毒治疗期间周围神经病的发病。
PLoS One. 2020 Oct 15;15(10):e0239758. doi: 10.1371/journal.pone.0239758. eCollection 2020.
6
Leukocyte telomere length is associated with iron overload in male adults with hereditary hemochromatosis.白细胞端粒长度与遗传性血色素沉着症男性成人铁过载相关。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20201916.
7
Transferrin and H-ferritin involvement in brain iron acquisition during postnatal development: impact of sex and genotype.转铁蛋白和 H 铁蛋白在出生后发育过程中脑铁摄取中的作用:性别和基因型的影响。
J Neurochem. 2020 Feb;152(3):381-396. doi: 10.1111/jnc.14834. Epub 2019 Aug 22.
8
Iron at the Centre of Interactions.铁处于相互作用的中心。
Front Cell Infect Microbiol. 2018 Jun 5;8:185. doi: 10.3389/fcimb.2018.00185. eCollection 2018.
9
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.去铁胺、去铁酮和地拉罗司铁螯合疗法治疗非输血依赖型地中海贫血综合征铁过载患者的疗效和安全性。
Drug Des Devel Ther. 2016 Jan 29;10:465-81. doi: 10.2147/DDDT.S79458. eCollection 2016.
10
Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation.去铁斯若对异基因造血干细胞移植后铁蛋白水平升高的非地中海贫血患者的疗效及安全性
Bone Marrow Transplant. 2016 Jan;51(1):89-95. doi: 10.1038/bmt.2015.204. Epub 2015 Sep 14.

本文引用的文献

1
Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry.飞行时间质谱法定量测定铁调素的进展。
PLoS One. 2008 Jul 16;3(7):e2706. doi: 10.1371/journal.pone.0002706.
2
A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.TMPRSS6基因发生突变,该基因编码一种抑制铁调素生成的跨膜丝氨酸蛋白酶,与口服铁剂治疗无效的家族性缺铁性贫血有关。
Haematologica. 2008 Oct;93(10):1473-9. doi: 10.3324/haematol.13342. Epub 2008 Jul 4.
3
Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency.一名患有小细胞贫血和缺铁症的患者,其TMPRSS6基因存在两个无义突变。
Blood. 2008 Sep 1;112(5):2089-91. doi: 10.1182/blood-2008-05-154740. Epub 2008 Jul 2.
4
Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis.膜结合丝氨酸蛋白酶matriptase-2(Tmprss6)是铁稳态的重要调节因子。
Blood. 2008 Sep 15;112(6):2539-45. doi: 10.1182/blood-2008-04-149773. Epub 2008 Jun 3.
5
Iron-overload-related disease in HFE hereditary hemochromatosis.HFE 遗传性血色素沉着症中与铁过载相关的疾病。
N Engl J Med. 2008 May 22;358(21):2293-4; author reply 2294-5. doi: 10.1056/NEJMc080330.
6
The serine protease TMPRSS6 is required to sense iron deficiency.丝氨酸蛋白酶TMPRSS6是感知缺铁所必需的。
Science. 2008 May 23;320(5879):1088-92. doi: 10.1126/science.1157121. Epub 2008 May 1.
7
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).TMPRSS6基因的突变会导致铁难治性缺铁性贫血(IRIDA)。
Nat Genet. 2008 May;40(5):569-71. doi: 10.1038/ng.130. Epub 2008 Apr 13.
8
Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha.促红细胞生成素通过EPOR信号传导和C/EBPα的调节介导肝细胞中的铁调素表达。
Blood. 2008 Jun 15;111(12):5727-33. doi: 10.1182/blood-2007-08-106195. Epub 2008 Mar 7.
9
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.转铁蛋白受体调节铁调素表达的Hfe依赖性调控。
Cell Metab. 2008 Mar;7(3):205-14. doi: 10.1016/j.cmet.2007.11.016.
10
2-Oxoglutarate-dependent oxygenases control hepcidin gene expression.2-氧代戊二酸依赖性加氧酶控制铁调素基因表达。
J Hepatol. 2008 May;48(5):801-10. doi: 10.1016/j.jhep.2007.12.021. Epub 2008 Feb 13.

血色素沉着症蛋白HFE的功能:来自动物模型的经验教训。

Function of the hemochromatosis protein HFE: Lessons from animal models.

作者信息

Pantopoulos Kostas

出版信息

World J Gastroenterol. 2008 Dec 7;14(45):6893-901. doi: 10.3748/wjg.14.6893.

DOI:10.3748/wjg.14.6893
PMID:19058322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2773850/
Abstract

Hereditary hemochromatosis (HH) is caused by chronic hyperabsorption of dietary iron. Progressive accumulation of excess iron within tissue parenchymal cells may lead to severe organ damage. The most prevalent type of HH is linked to mutations in the HFE gene, encoding an atypical major histocompatibility complex class I molecule. Shortly after its discovery in 1996, the hemochromatosis protein HFE was shown to physically interact with transferrin receptor 1 (TfR1) and impair the uptake of transferrin-bound iron in cells. However, these findings provided no clue why HFE mutations associate with systemic iron overload. It was later established that all forms of HH result from misregulation of hepcidin expression. This liver-derived circulating peptide hormone controls iron efflux from duodenal enterocytes and reticuloendothelial macrophages by promoting the degradation of the iron exporter ferroportin. Recent studies with animal models of HH uncover a crucial role of HFE as a hepatocyte iron sensor and upstream regulator of hepcidin. Thus, hepatocyte HFE is indispensable for signaling to hepcidin, presumably as a constituent of a larger iron-sensing complex. A working model postulates that the signaling activity of HFE is silenced when the protein is bound to TfR1. An increase in the iron saturation of plasma transferrin leads to displacement of TfR1 from HFE and assembly of the putative iron-sensing complex. In this way, iron uptake by the hepatocyte is translated into upregulation of hepcidin, reinforcing the concept that the liver is the major regulatory site for systemic iron homeostasis, and not merely an iron storage depot.

摘要

遗传性血色素沉着症(HH)是由饮食中铁的慢性过度吸收引起的。组织实质细胞内过量铁的渐进性积累可能导致严重的器官损伤。最常见的HH类型与HFE基因的突变有关,该基因编码一种非典型的主要组织相容性复合体I类分子。1996年发现血色素沉着症蛋白HFE后不久,就发现它与转铁蛋白受体1(TfR1)发生物理相互作用,并损害细胞中转铁蛋白结合铁的摄取。然而,这些发现并未揭示HFE突变与全身铁过载相关的原因。后来确定,所有形式的HH都是由铁调素表达失调引起的。这种肝脏来源的循环肽激素通过促进铁输出蛋白铁转运蛋白的降解来控制十二指肠肠上皮细胞和网状内皮巨噬细胞的铁外流。最近对HH动物模型的研究揭示了HFE作为肝细胞铁传感器和铁调素上游调节因子的关键作用。因此,肝细胞HFE对于向铁调素发出信号必不可少,大概是作为更大的铁传感复合体的一个组成部分。一个工作模型假设,当该蛋白与TfR1结合时,HFE的信号活性被沉默。血浆转铁蛋白铁饱和度的增加导致TfR1从HFE上解离,并组装假定的铁传感复合体。通过这种方式,肝细胞对铁的摄取转化为铁调素的上调,强化了肝脏是全身铁稳态的主要调节部位,而不仅仅是一个铁储存库的概念。